CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) Short Interest Down 88.3% in March

CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) was the recipient of a significant drop in short interest during the month of March. As of March 13th, there was short interest totaling 1,593 shares, a drop of 88.3% from the February 26th total of 13,626 shares. Based on an average daily volume of 4,605 shares, the short-interest ratio is currently 0.3 days.

CSPC Pharmaceutical Group Stock Down 3.2%

CSPCY stock traded down C$0.14 on Thursday, reaching C$4.10. 1,286 shares of the company traded hands, compared to its average volume of 4,898. The firm has a fifty day simple moving average of C$4.88 and a 200-day simple moving average of C$4.57. CSPC Pharmaceutical Group has a one year low of C$2.36 and a one year high of C$5.83.

About CSPC Pharmaceutical Group

CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. Established in 1979, the group has grown through organic expansion and strategic acquisitions to become one of the country’s leading manufacturers of active pharmaceutical ingredients (APIs), generic formulations and innovative drug candidates. CSPC is publicly traded in Hong Kong (HKEX: 1093) and maintains American Depositary Receipts on the OTC market (OTCMKTS: CSPCY), reflecting its dual focus on domestic market leadership and international visibility.

The company operates through three primary business segments: bulk pharmaceuticals, finished dosage forms and research-driven products.